Pure Biologics (WAR:PUR) EPS (Basic) : zł-6.13 (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics EPS (Basic)?

Pure Biologics's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was zł-0.23. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was zł-6.13.

Pure Biologics's EPS (Diluted) for the three months ended in Sep. 2024 was zł-0.23. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was zł-6.13.

Pure Biologics's EPS without NRI for the three months ended in Sep. 2024 was zł-0.47. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -13.89.

During the past 3 years, the average EPS without NRI Growth Rate was -14.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -68.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Pure Biologics's highest 3-Year average EPS without NRI Growth Rate was -14.30% per year. The lowest was -172.30% per year. And the median was -95.30% per year.

Pure Biologics EPS (Basic) Historical Data

The historical data trend for Pure Biologics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Biologics EPS (Basic) Chart

Pure Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-2.75

-7.11

-5.30

-11.36

-11.19

Pure Biologics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															-2.40	-3.44	-1.49	-0.97	-0.23

Pure Biologics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pure Biologics's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-35.694	-	0)	/	3.189
	=	-11.19

Pure Biologics's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.817	-	0)	/	3.532
	=	-0.23

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-6.13

Pure Biologics (WAR:PUR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Pure Biologics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Pure Biologics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pure Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (WAR:PUR) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.purebiologics.pl

Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

Pure Biologics Headlines

No Headlines